<?xml version = '1.0' encoding = 'UTF-8'?>
<?xml-stylesheet href="/rss/styledrssBMC.css" type="text/css"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:extra="http://www.biomedcentral.com/xml/schemas/extra/" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:cc="http://web.resource.org/cc/">
	<channel rdf:about="http://www.biomedcentral.com/rss">
		<extra:info rdf:parseType="Literal">
			<html:div xmlns:html="http://www.w3.org/1999/xhtml" style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif">
				<html:span style="font-weight:bold">This is an RSS newsfeed from BioMed Central</html:span>
				<html:br/>
				<html:span style="font-size: 12px;">It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit <html:br/><html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">http://www.biomedcentral.com/info/about/rss/</html:a><html:br/>
				</html:span>
			</html:div>
		</extra:info>
		<title>BMC Neuroscience - Latest articles</title>
		<link>http://www.biomedcentral.com/bmcneurosci/</link>
		<description>The latest articles from BMC Neuroscience (ISSN 1471-2202) published by 
				
				BioMed Central
		</description>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        <items>
            <rdf:Seq>
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2202/9/43"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2202/9/42"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2202/9/41"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2202/9/40"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2202/9/39"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2202/9/38"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2202/9/37"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2202/9/36"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2202/9/35"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2202/9/34"/>			    
            
            </rdf:Seq>
        </items>
    </channel>  
    
		<item rdf:about="http://www.biomedcentral.com/1471-2202/9/43">
            
            <title>Expression profile of the entire family of Adhesion G protein-coupled receptors in mouse and rat</title>
			<description>Background:
The Adhesion G protein-coupled receptors (GPCRs) are membrane-bound receptors with long N termini. This family has 33 members in humans. Several Adhesion GPCRs are known to have important physiological functions in CNS development and immune system response mediated by large cell surface ligands. However, the majority of Adhesion GPCRs are still poorly studied orphans with unknown functions.
Results:
In this study we performed the extensive tissue localization analysis of the entire Adhesion GPCR family in rat and mouse. By applying the quantitative real-time PCR technique we have produced comparable expression profile for each of the members in the Adhesion family. The results are compared with literature data and data from the Allen Brain Atlas project. Our results suggest that the majority of the Adhesion GPCRs are either expressed in the CNS or ubiquitously. In addition the Adhesion GPCRs from the same phylogenetic group have either predominant CNS or peripheral expression, although each of their expression profile is unique. 
Conclusions:
Our findings indicate that many of Adhesion GPCRs are expressed, and most probably, have function in CNS. The related Adhesion GPCRs are well conserved in their structure and interestingly have considerable overlap in their expression profiles, suggesting similarities among the physiological roles for members within many of the phylogenetically related clusters. </description>
			<link>http://www.biomedcentral.com/1471-2202/9/43</link>
			
			 	<dc:creator>Tatjana Haitina, Fredrik Olsson, Olga Stephansson, Johan Alsio, Erika Roman, Ted Ebendal, Helgi B Schioth and Robert Fredriksson</dc:creator>
			
			<dc:source>BMC Neuroscience 2008, 9:43</dc:source>
			<dc:date>2008-04-29</dc:date>
			<dc:identifier>doi:10.1186/1471-2202-9-43</dc:identifier>
			
			
							
					<prism:publicationName>BMC Neuroscience</prism:publicationName>
					
			
							
					<prism:issn>1471-2202</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>43</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-29</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2202/9/42">
            
            <title>Isolation of neuronal chromatin from brain tissue</title>
			<description>Background:
DNA-protein interactions in mature brain are increasingly recognized as key regulators for behavioral plasticity and neuronal dysfunction in chronic neuropsychiatric disease. However, chromatin assays typically lack single cell resolution, and therefore little is known about chromatin regulation of differentiated neuronal nuclei that reside in brain parenchyma intermingled with various types of non-neuronal cells. 
Results:
Here, we describe a protocol to selectively tag neuronal nuclei from adult brain either by (anti-NeuN) immunolabeling or transgene-derived histone H2B-GFP fusion protein for subsequent fluorescence-activated sorting and chromatin immunoprecipitation (ChIP). To illustrate an example, we compared histone H3 lysine 4 and 9 methylation marks at select gene promoters in neuronal, non-neuronal and unsorted chromatin from adult mouse forebrain and human cerebral cortex, and provide evidence for neuron-specific histone methylation signatures.
Conclusions:
With the modifications detailed in this protocol, the method can be used to collect nuclei from specific subtypes of neurons from any brain region for subsequent ChIP with native/un-fixed or crosslinked chromatin preparations. Starting with the harvest of brain tissue, ChIP-ready neuronal nuclei can be obtained within one day.  </description>
			<link>http://www.biomedcentral.com/1471-2202/9/42</link>
			
			 	<dc:creator>Yan Jiang, Anouch Matevossian, Hsien-Sung Huang, Juerg Straubhaar and Schahram Akbarian</dc:creator>
			
			<dc:source>BMC Neuroscience 2008, 9:42</dc:source>
			<dc:date>2008-04-28</dc:date>
			<dc:identifier>doi:10.1186/1471-2202-9-42</dc:identifier>
			
			
							
					<prism:publicationName>BMC Neuroscience</prism:publicationName>
					
			
							
					<prism:issn>1471-2202</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>42</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-28</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2202/9/41">
            
            <title>Dysfunctional GABAergic inhibition in the prefrontal cortex leading to "psychotic" hyperactivation</title>
			<description>Background:
The GABAergic system in the brain seems to be dysfunctional in various psychiatric disorders. Many studies have suggested so far that, in schizophrenia patients, GABAergic inhibition is selectively but consistently reduced in the prefrontal cortex (PFC).
Results:
This study used a computational model of the PFC to investigate the dynamics of the PFC circuit with and without chandelier cells and other GABAergic interneurons. The inhibition by GABAergic interneurons other than chandelier cells effectively regulated the PFC activity with rather low or modest levels of dopaminergic neurotransmission. This activity of the PFC is associated with normal cognitive functions and has an inverted-U shaped profile of dopaminergic modulation. In contrast, the chandelier cell-type inhibition affected only the PFC circuit dynamics in hyperdopaminergic conditions. Reduction of chandelier cell-type inhibition resulted in bistable dynamics of the PFC circuit, in which the upper stable state is associated with a hyperactive mode. When both types of inhibition were reduced, this hyperactive mode and the conventional inverted-U mode merged.
Conclusions:
The results of our simulation suggest that, in schizophrenia, a reduction of GABAergic inhibition increases vulnerability to psychosis by (i) producing the hyperactive mode of the PFC with hyperdopaminergic neurotransmission by dysfunctional chandelier cells and (ii) increasing the probability of the transition to the hyperactive mode from the conventional inverted-U mode by dysfunctional GABAergic interneurons.</description>
			<link>http://www.biomedcentral.com/1471-2202/9/41</link>
			
			 	<dc:creator>Shoji Tanaka</dc:creator>
			
			<dc:source>BMC Neuroscience 2008, 9:41</dc:source>
			<dc:date>2008-04-25</dc:date>
			<dc:identifier>doi:10.1186/1471-2202-9-41</dc:identifier>
			
			
							
					<prism:publicationName>BMC Neuroscience</prism:publicationName>
					
			
							
					<prism:issn>1471-2202</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>41</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-25</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2202/9/40">
            
            <title>Identification of Tmem10/Opalin as a novel marker for oligodendrocytes using gene expression profiling</title>
			<description>Background:
During the development of the central nervous system, oligodendrocytes generate large amounts of myelin, a multilayered insulating membrane that ensheathes axons, thereby allowing the fast conduction of the action potential and maintaining axonal integrity. Differentiation of oligodendrocytes to myelin-forming cells requires the downregulation of RhoA GTPase activity.
Results:
To gain insights into the molecular mechanisms of oligodendrocyte differentiation, we performed microarray expression profiling of the oligodendroglial cell line, Oli-neu, treated with the Rho kinase (ROCK) inhibitor, Y-27632 or with conditioned neuronal medium. This resulted in the identification of the transmembrane protein 10 (Tmem10/Opalin), a novel type I transmembrane protein enriched in differentiating oligodendrocytes. In primary cultures, Tmem10 was abundantly expressed in O4-positive oligodendrocytes, but not in oligodendroglial precursor cells, astrocytes, microglia or neurons. In mature oligodendrocytes Tmem10 was enriched in the rims and processes of the cells and was only found to a lesser extent in the membrane sheets.
Conclusions:
Together, our results demonstrate that Tmem10 is a novel marker for in vitro generated oligodendrocytes.</description>
			<link>http://www.biomedcentral.com/1471-2202/9/40</link>
			
			 	<dc:creator>Angelika Kippert, Katarina Trajkovic, Dirk Fitzner, Lennart Opitz and Mikael Simons</dc:creator>
			
			<dc:source>BMC Neuroscience 2008, 9:40</dc:source>
			<dc:date>2008-04-25</dc:date>
			<dc:identifier>doi:10.1186/1471-2202-9-40</dc:identifier>
			
			
							
					<prism:publicationName>BMC Neuroscience</prism:publicationName>
					
			
							
					<prism:issn>1471-2202</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>40</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-25</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2202/9/39">
            
            <title>Extensive neuroadaptive changes in cortical gene-transcript expressions of the glutamate system in response to repeated intermittent MDMA administration in adolescent rats</title>
			<description>Background:
Many studies have focused on the implication of the serotonin and dopamine systems in neuroadaptive responses to the recreational drug 3,4-methylenedioxy-metamphetamine (MDMA). Less attention has been given to the major excitatory neurotransmitter glutamate known to be implicated in schizophrenia and drug addiction. The aim of the present study was to investigate the effect of repeated intermittent MDMA administration upon gene-transcript expression of the glutamate transporters (EAAT1, EAAT2-1, EAAT2-2), the glutamate receptor subunits of AMPA (GluR1, GluR2, GluR3), the glutamate receptor subunits of NMDA (NR1, NR2A and NR2B), as well as metabotropic glutamate receptors (mGluR1, mGluR2, mGluR3, mGluR5) in six different brain regions. Adolescent male Sprague Dawley rats received MDMA at the doses of 3 &#215; 1 and 3 &#215; 5 mg/kg/day, or 3&#215; vehicle 3 hours apart, every 7th day for 4 weeks. The gene-transcript levels were assessed using real-time PCR validated with a range of housekeeping genes.
Results:
The findings showed pronounced enhancements in gene-transcript expression of GluR2, mGluR1, mGluR5, NR1, NR2A, NR2B, EAAT1, and EAAT2-2 in the cortex at bregma +1.6. In the caudate putamen, mRNA levels of GluR3, NR2A, and NR2B receptor subunits were significantly increased. In contrast, the gene-transcript expression of GluR1 was reduced in the hippocampus. In the hypothalamus, there was a significant increase of GluR1, GluR3, mGluR1, and mGluR3 gene-transcript expressions.
Conclusion:
Repeated intermittent MDMA administration induces neuroadaptive changes in gene-transcript expressions of glutamatergic NMDA and AMPA receptor subunits, metabotropic receptors and transporters in regions of the brain regulating reward-related associative learning, cognition, and memory and neuro-endocrine functions.</description>
			<link>http://www.biomedcentral.com/1471-2202/9/39</link>
			
			 	<dc:creator>Anna MS Kindlundh-H&#246;gberg, Anna Blomqvist, Rana Malki and Helgi B Schi&#246;th</dc:creator>
			
			<dc:source>BMC Neuroscience 2008, 9:39</dc:source>
			<dc:date>2008-04-17</dc:date>
			<dc:identifier>doi:10.1186/1471-2202-9-39</dc:identifier>
			
			
							
					<prism:publicationName>BMC Neuroscience</prism:publicationName>
					
			
							
					<prism:issn>1471-2202</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>39</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-17</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2202/9/38">
            
            <title>Elucidating a normal function of huntingtin by functional and microarray analysis of huntingtin-null mouse embryonic fibroblasts</title>
			<description>Background:
The polyglutamine expansion in huntingtin (Htt) protein is a cause of Huntington's disease (HD).  Htt is an essential gene as  deletion of the mouse Htt gene homolog (Hdh) is embryonic lethal in mice. Therefore, in addition to elucidating the mechanisms responsible for polyQ-mediated pathology, it is also important to understand the normal function of Htt protein for both basic biology and for HD.
Results:
To systematically search for a mouse Htt function, we took advantage of the Hdh +/- and Hdh-floxed mice and generated four mouse embryonic fibroblast (MEF) cells lines which contain a single copy of the Hdh gene (Hdh-HET) and four MEF lines in which the Hdh gene was deleted (Hdh-KO).   The function of Htt in calcium (Ca2+) signaling was analyzed in Ca2+ imaging experiments with generated cell lines.   We found that the cytoplasmic Ca2+ spikes resulting from the activation of inositol 1,4,5-trisphosphate receptor (InsP3R) and the ensuing mitochondrial Ca2+ signals were suppressed in the Hdh-KO cells when compared to Hdh-HET cells.  Furthermore,  in experiments with permeabilized cells we found that the InsP3-sensitivity of Ca2+ mobilization from endoplasmic reticulum was reduced in Hdh-KO cells.  These results indicated that Htt plays an important role in modulating InsP3R-mediated Ca2+ signaling.  To further evaluate function of Htt, we performed genome-wide transcription profiling of generated  Hdh-HET and Hdh-KO cells by microarray.  Our results revealed that 106 unique transcripts were downregulated by more than two-fold with p &lt; 0.05 and 173 unique transcripts were upregulated at least two-fold with p &lt; 0.05 in Hdh-KO cells when compared to Hdh-HET cells.  The microarray results were confirmed by quantitative real-time PCR for a number of affected transcripts.  Several signaling pathways affected by Hdh gene deletion were identified from annotation of the microarray results.  
Conclusions:
Functional analyisis of generated Htt-null MEF cells revealed that Htt plays a direct role in Ca2+ signaling by modulating InsP3R sensitivity to InsP3.  The genome-wide transcriptional profiling of Htt-null cells yielded novel and unique information about the normal function of Htt in cells, which may contribute to our understanding and treatment of HD.</description>
			<link>http://www.biomedcentral.com/1471-2202/9/38</link>
			
			 	<dc:creator>Hua Zhang, Sudipto Das, Quan-Zhen Li, Ioannis Dragatsis, Joyce Repa, Scott Zeitlin, Gyorgy Hajnoczky and Ilya Bezprozvanny</dc:creator>
			
			<dc:source>BMC Neuroscience 2008, 9:38</dc:source>
			<dc:date>2008-04-15</dc:date>
			<dc:identifier>doi:10.1186/1471-2202-9-38</dc:identifier>
			
			
							
					<prism:publicationName>BMC Neuroscience</prism:publicationName>
					
			
							
					<prism:issn>1471-2202</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>38</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-15</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2202/9/37">
            
            <title>Enhanced nigrostriatal neuron-specific, long-term expression by using neural-specific promoters in combination with targeted gene transfer by modified helper virus-free HSV-1 vector particles</title>
			<description>Background:
Direct gene transfer into neurons has potential for developing gene therapy treatments for specific neurological conditions, and for elucidating neuronal physiology. Due to the complex cellular composition of specific brain areas, neuronal type-specific recombinant gene expression is required for many potential applications of neuronal gene transfer. One approach is to target gene transfer to a specific type of neuron. We developed modified Herpes Simplex Virus (HSV-1) particles that contain chimeric glycoprotein C (gC) &#8211; glial cell line-derived neurotrophic factor (GDNF) or brain-derived neurotrophic factor (BDNF) proteins. HSV-1 vector particles containing either gC &#8211; GDNF or gC &#8211; BDNF target gene transfer to nigrostriatal neurons, which contain specific receptors for GDNF or BDNF. A second approach to achieve neuronal type-specific expression is to use a cell type-specific promoter, and we have used the tyrosine hydroxylase (TH) promoter to restrict expression to catecholaminergic neurons or a modified neurofilament heavy gene promoter to restrict expression to neurons, and both of these promoters support long-term expression from HSV-1 vectors. To both improve nigrostriatal-neuron specific expression, and to establish that targeted gene transfer can be followed by long-term expression, we performed targeted gene transfer with vectors that support long-term, neuronal-specific expression.
Results:
Helper virus-free HSV-1 vector packaging was performed using either gC &#8211; GDNF or gC &#8211; BDNF and vectors that contain either the TH promoter or the modified neurofilament heavy gene promoter. Vector stocks were injected into the midbrain proximal to the substantia nigra, and the rats were sacrificed at either 4 days or 1 month after gene transfer. Immunofluorescent costaining was performed to detect both recombinant gene products and nigrostriatal neurons. The combination of targeted gene transfer with neuronal-specific promoters improved nigrostriatal neuron-specific expression (83 to 93%) compared to either approach alone, and supported long-term (1 month) expression at levels similar to those observed using untargeted gene transfer.
Conclusion:
Targeted gene transfer can be used in combination with neuronal-specific promoters to achieve a high level of nigrostriatal neuron-specific expression. Targeted gene transfer can be followed by long-term expression. Nigrostriatal neuron-specific expression may be useful for specific gene therapy approaches to Parkinson's disease or for genetic analyses of nigrostriatal neuron physiology.</description>
			<link>http://www.biomedcentral.com/1471-2202/9/37</link>
			
			 	<dc:creator>Haiyan Cao, Guo-rong Zhang, Xiaodan Wang, Lingxin Kong and Alfred I Geller</dc:creator>
			
			<dc:source>BMC Neuroscience 2008, 9:37</dc:source>
			<dc:date>2008-04-10</dc:date>
			<dc:identifier>doi:10.1186/1471-2202-9-37</dc:identifier>
			
			
							
					<prism:publicationName>BMC Neuroscience</prism:publicationName>
					
			
							
					<prism:issn>1471-2202</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>37</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-10</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2202/9/36">
            
            <title>Protein fingerprints of cultured CA3-CA1 hippocampal neurons: comparative analysis of the distribution of synaptosomal and cytosolic proteins</title>
			<description>Background:
All studies aimed at understanding complex molecular changes occurring at synapses face the problem of how a complete view of the synaptic proteome and of its changes can be efficiently met. This is highly desirable when synaptic plasticity processes are analyzed since the structure and the biochemistry of neurons and synapses get completely reshaped. Because most molecular studies of synapses are nowadays mainly or at least in part based on protein extracts from neuronal cultures, this is not a feasible option: these simplified versions of the brain tissue on one hand provide an homogeneous pure population of neurons but on the other yield only tiny amounts of proteins, many orders of magnitude smaller than conventional brain tissue. As a way to overcome this limitation and to find a simple way to screen for protein changes at cultured synapses, we have produced and characterized two dimensional electrophoresis (2DE) maps of the synaptic proteome of CA3-CA1 hippocampal neurons in culture.
Results:
To obtain 2D maps, hippocampal cultures were mass produced and after synaptic maturation, proteins were extracted following subfractionation procedures and separated by 2D gel electrophoresis. Similar maps were obtained for the crude cytosol of cultured neurons and for synaptosomes purified from CA3-CA1 hippocampal tissue. To efficiently compare these different maps some clearly identifiable reference points were molecularly identified by mass spectrometry and immunolabeling methods. This information was used to run a differential analysis and establish homologies and dissimilarities in these 2D protein profiles.
Conclusion:
Because reproducible fingerprints of cultured synapses were clearly obtained, we believe that our mapping effort could represent a simple tool to screen for protein expression and/or protein localization changes in CA3-CA1 hippocampal neurons following plasticity.</description>
			<link>http://www.biomedcentral.com/1471-2202/9/36</link>
			
			 	<dc:creator>Valeria Corti, Yovan Sanchez-Ruiz, Giovanni Piccoli, Andrea Bergamaschi, Carlo V Cannistraci, Linda Pattini, Sergio Cerutti, Angela Bachi, Massimo Alessio and Antonio Malgaroli</dc:creator>
			
			<dc:source>BMC Neuroscience 2008, 9:36</dc:source>
			<dc:date>2008-04-10</dc:date>
			<dc:identifier>doi:10.1186/1471-2202-9-36</dc:identifier>
			
			
							
					<prism:publicationName>BMC Neuroscience</prism:publicationName>
					
			
							
					<prism:issn>1471-2202</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>36</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-10</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2202/9/35">
            
            <title>Non-cell autonomous impairment of oligodendrocyte differentiation precedes CNS degeneration in the Zitter rat: Implications of macrophage/microglial activation in the pathogenesis</title>
			<description>Background:
The zitter (zi/zi) rat, a loss-of-function mutant of the glycosylated transmembrane protein attractin (atrn), exhibits widespread age-dependent spongiform degeneration, hypomyelination, and abnormal metabolism of reactive oxygen species (ROS) in the brain. To date, the mechanisms underlying these phenotypes have remained unclear.
Results:
Here, we show differentiation defects in zi/zi oligodendrocytes, accompanied by aberrant extension of cell-processes and hypomyelination. Axonal bundles were relatively preserved during postnatal development. With increasing in age, the injured oligodendrocytes in zi/zi rats become pathological, as evidenced by the accumulation of iron in their cell bodies. Immunohistochemical analysis revealed that atrn expression was absent from an oligodendrocyte lineage, including A2B5-positive progenitors and CNPase-positive differentiated cells. The number and distribution of Olig2-positive oligodendrocyte progenitors was unchanged in the zi/zi brain. Furthermore, an in vitro differentiation assay of cultured oligodendrocyte progenitors prepared from zi/zi brains revealed their normal competence for proliferation and differentiation into mature oligodendrocytes. Interestingly, we demonstrated the accelerated recruitment of ED1-positive macrophages/microglia to the developing zi/zi brain parenchyma prior to the onset of hypomyelination. Semiquantitative RT-PCR analysis revealed a significant up-regulation of CD26 and IL1-&#946; in the zi/zi brain during this early postnatal stage.
Conclusion:
We demonstrated that the onset of the impairment of oligodendrocyte differentiation occurs in a non-cell autonomous manner in zi/zi rats. Hypomyelination of oligodendrocytes was not due to a failure of the intrinsic program of oligodendrocytes, but rather, was caused by extrinsic factors that interrupt oligodendrocyte development. It is likely that macrophage/microglial activation in the zi/zi CNS leads to disturbances in oligodendrocyte differentiation via deleterious extrinsic factors, such as the cytokine IL1-&#946; or ROS. Atrn might be involved in the activation of brain macrophages/microglia by suppressing excessive migration of monocytes into the CNS, or by accelerating the transformation of brain monocytes into resting microglia. Understanding the pathogenesis of the zi/zi rat may provide novel insights into the developmental interaction betweens macrophages/microglia and cells of an oligodendrocyte lineage.</description>
			<link>http://www.biomedcentral.com/1471-2202/9/35</link>
			
			 	<dc:creator>Shin-ichi Sakakibara, Kazuhiko Nakadate, Shigeo Ookawara and Shuichi Ueda</dc:creator>
			
			<dc:source>BMC Neuroscience 2008, 9:35</dc:source>
			<dc:date>2008-04-05</dc:date>
			<dc:identifier>doi:10.1186/1471-2202-9-35</dc:identifier>
			
			
							
					<prism:publicationName>BMC Neuroscience</prism:publicationName>
					
			
							
					<prism:issn>1471-2202</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>35</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-05</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1471-2202/9/34">
            
            <title>Wheel running from a juvenile age delays onset of specific motor deficits but does not alter protein aggregate density in a mouse model of Huntington's disease</title>
			<description>Background:
Huntington's disease (HD) is a neurodegenerative disorder predominantly affecting the cerebral cortex and striatum. Transgenic mice (R6/1 line), expressing a CAG repeat encoding an expanded polyglutamine tract in the N-terminus of the huntingtin protein, closely model HD. We have previously shown that environmental enrichment of these HD mice delays the onset of motor deficits. Furthermore, wheel running initiated in adulthood ameliorates the rear-paw clasping motor sign, but not an accelerating rotarod deficit.
Results:
We have now examined the effects of enhanced physical activity via wheel running, commenced at a juvenile age (4 weeks), with respect to the onset of various behavioral deficits and their neuropathological correlates in R6/1 HD mice. HD mice housed post-weaning with running wheels only, to enhance voluntary physical exercise, have delayed onset of a motor co-ordination deficit on the static horizontal rod, as well as rear-paw clasping, although the accelerating rotarod deficit remains unaffected. Both wheel running and environmental enrichment rescued HD-induced abnormal habituation of locomotor activity and exploratory behavior in the open field. We have found that neither environment enrichment nor wheel running ameliorates the shrinkage of the striatum and anterior cingulate cortex (ACC) in HD mice, nor the overall decrease in brain weight, measured at 9 months of age. At this age, the density of ubiquitinated protein aggregates in the striatum and ACC is also not significantly ameliorated by environmental enrichment or wheel running.
Conclusion:
These results indicate that enhanced voluntary physical activity, commenced at an early presymptomatic stage, contributes to the positive effects of environmental enrichment. However, sensory and cognitive stimulation, as well as motor stimulation not associated with running, may constitute major components of the therapeutic benefits associated with enrichment. Comparison of different environmental manipulations, performed in specific time windows, can identify critical periods for the induction of neuroprotective 'brain reserve' in animal models of HD and related neurodegenerative diseases.</description>
			<link>http://www.biomedcentral.com/1471-2202/9/34</link>
			
			 	<dc:creator>Anton van Dellen, Patricia M Cordery, Tara L Spires, Colin Blakemore and Anthony J Hannan</dc:creator>
			
			<dc:source>BMC Neuroscience 2008, 9:34</dc:source>
			<dc:date>2008-04-01</dc:date>
			<dc:identifier>doi:10.1186/1471-2202-9-34</dc:identifier>
			
			
							
					<prism:publicationName>BMC Neuroscience</prism:publicationName>
					
			
							
					<prism:issn>1471-2202</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>34</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-01</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
		
    <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
         <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks"/>
	</cc:License>
</rdf:RDF>
